Hematological Malignancies
139
24
34
54
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
22 trials with published results (16%)
Research Maturity
54 completed trials (39% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
6.5%
9 terminated out of 139 trials
85.7%
-0.9% vs benchmark
8%
11 trials in Phase 3/4
41%
22 of 54 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 54 completed trials
Clinical Trials (139)
Durvalumab and Tremelimumab for Pediatric Malignancies
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
M-2018-334 in Hematological Malignancies
A Manualised Post-Traumatic Growth Intervention For People With Hematological Cancers In Greece
A Clinical Study to Evaluate CHT101 Injection in Subjects With Relapsed/Refractory T-Cell and B-Cell Hematologic Malignancies
A Phase I, Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Injection in Subjects With Relapsed/Refractory T-Cell and B-Cell Hematological Malignancies
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies
mNGS for IFD in Patients With Hematological Malignancies
Dose-range Finding Treosulfan-based Conditioning
Feasibility of the Use of Weighted Blankets to Improve Sleep Among Patients With Hematological Malignancies
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant
Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe
To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers
Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies